[Skip to Content]
[Skip to Content Landing]
Views 7,776
Citations 0
Research Letter
December 20, 2016

Prevalence of Immunosuppression Among US Adults, 2013

Author Affiliations
  • 1Division of Viral Diseases, US Centers for Disease Control and Prevention, Atlanta, Georgia
JAMA. 2016;316(23):2547-2548. doi:10.1001/jama.2016.16477

The number of immunosuppressed adults in the United States is unknown but thought to be increasing because of both greater life expectancy among immunosuppressed adults due to improvements in medical management, as well as new indications for immunosuppressive treatments.14 Immunosuppression increases the risks and severity of primary or reactivation infections; its prevalence has implications for food and water safety, tuberculosis control, vaccine programs, infection control strategies, outbreak preparedness, travel medicine, and other facets of public health.1 We present data on the prevalence of self-reported immunosuppressed adults in the United States.

First Page Preview View Large
First page PDF preview
First page PDF preview
×